PORKEROpen the app

Senate bill · 119th Congress · Latest step: Committee action

Preserve Access to Affordable Generics and Biosimilars Act

S. 1096Introduced Mar 24, 2025Policy area: Health

Official title: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.

Sponsor: Sen. Amy Klobuchar D-MN
Open in Bill Explorer →

Where it went

Latest action: Apr 10, 2025 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 46.

Vote results

No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).

Cosponsors

8 cosponsors — 3 Republicans, 5 Democrats

3 of 8 cosponsors (38%) are from the other party.

Richard Blumenthal (D-CT), Cory Booker (D-NJ), Kevin Cramer (R-ND), Richard Durbin (D-IL), Joni Ernst (R-IA), Chuck Grassley (R-IA), Mark Kelly (D-AZ), Peter Welch (D-VT).

More from the sponsor

Other 119th Congress bills sponsored by Sen. Amy Klobuchar.

Sponsor’s state and district

Minnesota in Congress

Open in Bill Explorer →

Data as of Sep 25, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.